Methods and compositions for treating melanoma
US-2024424002-A1 · Dec 26, 2024 · US
Compositions and methods for treatment of leukemia
US8993552B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8993552-B2 |
| Application number | US-87596810-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 3, 2010 |
| Priority date | Sep 4, 2009 |
| Publication date | Mar 31, 2015 |
| Grant date | Mar 31, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention relates generally to effective treatment leukemia. In particular, the present invention provides compositions and methods to inhibit the interaction of menin with MLL and MLL-fusion oncoproteins, and well as systems and methods to screen for such compositions.
First claim
Opening claim text (preview).
What is claimed is: 1. A pharmaceutical preparation comprising a compound having the structure or pharmaceutically acceptable salts of thereof: wherein R3 is: R1, R2, R4, R5, and/or R6 independently comprise: H, substituted or non-substituted alkyl, substituted…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8993552B2 cover?
- The invention relates generally to effective treatment leukemia. In particular, the present invention provides compositions and methods to inhibit the interaction of menin with MLL and MLL-fusion oncoproteins, and well as systems and methods to screen for such compositions.
- Who is the assignee on this patent?
- Grembecka Jolanta, Cierpicki Tomasz, Hess Jay, and 2 more
- What technology area does this patent fall under?
- Primary CPC classification A61K31/519. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).